Medtech Insight is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Abbott Diagnostics

Division of Abbott Laboratories Inc.

Latest From Abbott Diagnostics

NESTcc Test Case List Includes Apple Watch, Pelvic Mesh

The National Evaluation System for health Technology Coordinating Center announced 12 new test cases that use real-world evidence to examine medical device industry priorities. The list includes an Apple Watch study, as well as an FDA proposal on the use of pelvic mesh to treat urinary incontinence.

Health Technology Assessment Review Pathway

EU No-Deal Scenario Looms Still, But MHRA’s Reg Oversight Of UK Medtech On Hold

UK parliament’s indecision over how – or if – to enact Brexit saw the planned March 29 withdrawal deadline come and go. The default positions of the inter-ministerial Office for Lifesciences (OLS) and health-care products regulator (MHRA) are still to prepare for a no-deal exit from the EU.

United Kingdom Brexit

Blood-Collection Groups Must Test Blood For Chagas Disease Parasite, US FDA Says

Donated blood must be tested by blood-collection groups for evidence of infection with Trypanosoma cruzi, a parasite that causes Chagas disease – either for donation purposes or for use in manufacturing a medical device – FDA says in final guidance released Dec. 5.

Policy & Regulation In Vitro Diagnostics

Keeping Track: US FDA Approvals Of Mavyret, Idhifa, Vyxeos Headline Week Of Breakthroughs, Hematology And Hematology BTDs

The latest drug development news and highlights from our FDA Performance Tracker.

Approvals Biosimilars
See All

Company Information

  • Industry
  • In Vitro Diagnostics
  • Therapeutic Areas
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Parent & Subsidiaries
  • Abbott Laboratories Inc.
  • Senior Management
  • Miles White, CEO
    Thomas D Brown, SVP
    Jay Johnston, Corp. VP, Diagnostics and Operations
    Steve Weger, VP, Strat. Planning & Tech. Assessment
    Robert Parkinson, Pres. & COO
    James J Koziarz, PhD, VP, Diagnostic Products R&D
  • Contact Info
  • Abbott Diagnostics
    ,
Advertisement
Advertisement
UsernamePublicRestriction

Register